AstraZeneca has made a non-binding offer of about $10 billion for Rhythm Pharmaceuticals, Reuters reports. Rhythm’s latest results show the attraction of its rare-obesity franchise, but milestone payments complicate the headline price.
– Total Revenues increased 24.6% for the quarter over the prior year period to $79.9 million –– Organic Revenue Growth Rate* of 16.6% for the quarter –– Net income of $9.0 million
FAIRPORT, N.Y., Nov. 04, 2026 (GLOBE NEWSWIRE) — Seneca Foods Corporation (NASDAQ: SENEA, SENEB) (“Seneca” or the “Company”), one of North America’s leading providers of packaged fruits and vegetables with facilities located
GAAP Net Income of $159 million, or $1.15 per diluted shareAdjusted Operating Income of $164 million, or $1.19 per diluted shareReturn on Equity of 12.0% and Adjusted Operating Return on Equity of
ANDOVER, Mass., Nov. 04, 2026 (GLOBE NEWSWIRE) — MKS Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that its Board of Directors has approved a
Fiscal 2027 second quarter revenue increased 9%; constant currency organic revenue growth was 8% Fiscal 2027 second quarter as reported diluted EPS increased to $2.19; adjusted EPS per diluted share increased to
BETHESDA, Md., Nov. 04, 2026 (GLOBE NEWSWIRE) — Host Hotels & Resorts, Inc. (NASDAQ: HST) (the “Company”), the nation’s largest lodging real estate investment trust, today announced that it has acquired the
Quincy, MA, Nov. 04, 2026 (GLOBE NEWSWIRE) — Stran & Company, Inc. (“Stran” or the “Company”) (NASDAQ: SWAG) (NASDAQ: SWAGW), a leading outsourced marketing solutions provider that leverages its promotional products and
MALVERN, Pa., Nov. 04, 2026 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health and provider of NeuroStar® TMS technology and direct patient care through the Greenbrook network
Third Quarter 2026 Revenue Totaled $12.0 Million Third Quarter 2026 Net Income Attributable to Common Stockholders Totaled $4.2 Million, Funds from Operations Totaled $10.0 Million, and Adjusted Funds from Operations Totaled $10.3
Delivered Comparable Hotel RevPAR Growth of 8.8% and Comparable Hotel Total RevPAR Growth of 7.3% Acquired 1 Hotel Brooklyn Bridge and Renaissance Dallas at Plano Legacy West HotelAmended $2.5 Billion Credit Facility, Extending
Follow